Only about 40% of perinatally exposed infants were tested for hepatitis C virus (HCV), and less than 30% of eligible children ...
Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced the publication of a study in the Journal of Hepatology demonstrating the performance of HelioLiver™, ...
Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced the publication of a study in the Journal of Hepatology demonstrating the performance of HelioLivertm, ...
For Roslyn Mannon, MD, a single patient experience inspired her path to nephrology.“The patient talked passionately about how ...
Good afternoon, and welcome to Bausch Health's First Quarter 2026 Earnings Conference Call. My name is Garen Sarafian, Vice President of Investor Relations. Participating in today's call are Thomas ...
Viral hepatitis B and C—the two forms responsible for 95% of hepatitis-related deaths—claimed an estimated 1.34 million lives in 2024.
The World Health Organization on Tuesday said progress in eliminating hepatitis was too slow, with tools available to eliminate the disease that kills more than one million people annually.
Researchers at Cedars-Sinai Health Sciences University have discovered that utilizing organs from donors who are hepatitis C ...
Insulin resistance is a common extrahepatic manifestation of hepatitis C virus (HCV) infection (HCVi), but its mechanism is ...
Hepatitis C virus screening rates in pregnancy increased from 2014 to 2024 but remained below universal screening recommendations.
FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...
Personalized algorithms may quietly sabotage how people learn, nudging them into narrow tunnels of information even when they start with zero prior knowledge. In the study, participants using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results